Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | MGLL | Q99685 | 6/20 | 0.42 |
| ▸ | LMNA | P02545 | 5/20 | 0.42 |
| ▸ | HTT | P42858 | 4/20 | 0.42 |
| ▸ | ALDH2 | P05091 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | FBP1 | P09467 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27722887 | 0.91 | POLB (0.41) | CYP1A2CYP2C9CYP2C19POLBNOS3 | |
| SCHEMBL11850440 | 0.91 | MGLL (0.42) | CYP1A2CYP2C9CYP2C19POLBNOS3 | |
| SCHEMBL11169576 | 0.91 | MGLL (0.42) | CYP1A2CYP2C9CYP2C19POLBNOS3 | |
| SCHEMBL11043122 | 0.85 | — | — | |
| SCHEMBL29857470 | 0.83 | MGLL (0.43) | CYP1A2CYP2C9CYP2C19POLBNOS3 | |
| Guanidine SCHEMBL9056184 | 0.82 | NOS3 (0.47) | CYP1A2CYP2C9CYP2C19POLBNOS3 | |
| SCHEMBL8986674 | 0.82 | NOS3 (0.45) | CYP1A2CYP2C9CYP2C19POLBNOS3 | |
| SCHEMBL2362925 | 0.81 | ALDH1A1 (0.42) | CYP1A2CYP2C9CYP2C19POLBALDH1A1 | |
| SCHEMBL30446032 | 0.79 | ALDH1A1 (0.50) | CYP1A2CYP2C9CYP2C19ALDH1A1MGLL | |
| SCHEMBL11143218 | 0.79 | CYP1A2 (0.43) | CYP1A2CYP2C9CYP2C19POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12539650-B2 | Method for making embedded hydrogel contact lenses | ALCON INC. (CH) | 2026-02-03 | — | — | US | claimed |
| EP-4514595-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2025-03-05 | — | — | EP | claimed |
| EP-4240578-B1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | ALCON INC (CH) | 2024-12-18 | — | — | EP | claimed |
| US-11886045-B2 | Method for making photochromic contact lenses | ALCON INC. (CH) | 2024-01-30 | — | — | US | claimed |
| WO-2023209570-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-11-02 | — | — | WO | claimed |
| US-20230339149-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-10-26 | — | — | US | claimed |
| EP-4240578-A1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | Alcon Inc. (CH) | 2023-09-13 | — | — | EP | claimed |
| WO-2022097048-A1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | ALCON INC. (CH) | 2022-05-12 | — | — | WO | claimed |
| US-20220137433-A1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | ALCON INC. (CH) | 2022-05-05 | — | — | US | claimed |
| US-6265499-B1 | POLYMERIZING MIXTURE | MENICON CO., LTD. (JP) | 2001-07-24 | — | — | US | claimed |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-05-14 | — | — | US | disclosed |
| US-12539650-B2 | Method for making embedded hydrogel contact lenses | ALCON INC. (CH) | 2026-02-03 | — | — | US | disclosed |
| EP-4514595-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2025-03-05 | — | — | EP | disclosed |
| EP-4240578-B1 | METHOD FOR MAKING PHOTOCHROMIC CONTACT LENSES | ALCON INC (CH) | 2024-12-18 | — | — | EP | disclosed |
| US-11886045-B2 | Method for making photochromic contact lenses | ALCON INC. (CH) | 2024-01-30 | — | — | US | disclosed |
| US-6265499-B1 | POLYMERIZING MIXTURE | MENICON CO., LTD. (JP) | 2001-07-24 | — | — | US | disclosed |
| EP-0921134-A1 | Process for producing a shaped product | Menicon Co., Ltd. (JP) | 1999-06-09 | — | — | EP | disclosed |
| US-5866047-A | Process for producing a shaped product | MENICON CO., LTD. (JP) | 1999-02-02 | — | — | US | disclosed |
| EP-0814095-A2 | Process for producing a shaped product | Menicon Co., Ltd. (JP) | 1997-12-29 | — | — | EP | disclosed |
| EP-0421388-A2 | Positive-acting photoresist composition | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12539650-B2 | Method for making embedded hydrogel contact lenses | INF2, CRYZ, CRYAA | CYP1A2 849/4885CYP2C9 1867/4885CYP2C19 2132/4885 |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | CRYZ, CRYAB, CRYAA | CYP1A2 1256/4885CYP2C9 799/4885CYP2C19 961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.